MyFinsight
Home
Blog
About
Contact
Download
Download image
Maturities of investments
$110,873K
Proceeds from purchase of
espp shares
-$233K
Proceeds from exercise of
stock options
$138K
Net cash provided by
(used in) investing...
$63,411K
Net cash provided by
financing activities
$9K
Canceled cashflow
$47,462K
Canceled cashflow
$362K
Net decrease in
cash, cash...
-$13,331K
Canceled cashflow
$63,420K
Stock-based compensation
$6,821K
Depreciation and
amortization
$2,597K
Accrued expenses
(including related party...
$2,003K
Other receivables
(including related party...
-$79K
Purchases of investments
$44,875K
Purchases of property and
equipment
$2,587K
Payments to taxing
authorities related to...
$230K
Payments on finance
leases
$132K
Net cash used in
operating activities
-$76,751K
Canceled cashflow
$11,500K
Other income, net
$5,945K
Net income (loss)
-$83,865K
Canceled cashflow
$5,945K
Accretion of discounts and
amortization of premiums on...
$1,880K
Prepaid expenses and
other current assets
$1,534K
Accounts payable
(including related party...
-$760K
Other long-term
assets
$191K
Operating lease
right-of-use asset and lease...
-$21K
Operating expenses
$89,810K
Back
Back
Cash Flow
source: myfinsight.com
Artiva Biotherapeutics, Inc. (ARTV)
Artiva Biotherapeutics, Inc. (ARTV)